INCYTE CORPORATION Accrued Income Taxes, Current
INCYTE CORPORATION (INCY) had Accrued Income Taxes, Current of $5.93 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-04-28
- 2026-03-31: Accrued Income Taxes, Current $5.93M.
- 2025-12-31: Accrued Income Taxes, Current $4.75M.
- 2025-09-30: Accrued Income Taxes, Current $5.51M.
- 2025-06-30: Accrued Income Taxes, Current $5.39M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-03-31 | $5.93M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $4.75M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $5.51M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $5.39M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $91.70M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $23.78M 10-K · filed 2026-02-10 |
| 2024-09-30 | $33.15M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $32.40M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $126.76M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $42.30M 10-K · filed 2025-02-10 |
| 2022-12-31 | $7.11M 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |